In older clients, this is essential to be familiar with as polypharmacy is frequent and might potentiate the potential risk of DDIs and ADRs. Consequently, concurrent consumption of CYP2D6 inhibitors or inducers could potentiate or block tramadol conversion into ODT and This may boost or reduce efficacy/ADRs on the prescribed tramadol. Literature d